NM28-2746

N/A

Report date: 2026/03/19 17:18:39

Base Information

Drug NameNM28-2746
Drug Alias NameNM-28-2746NM28-2746NM28
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Anti-Serum albuminAnti-Mesothelin
TargetsT cell surface glycoprotein CD3Serum albuminMesothelin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesNumab Therapeutics Ag3sbio Inc
China Registration ClassN/A

Develop Information

Active Companies3sbio IncNumab Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A